MHRA approves use of Moderna COVID-19 vaccine in 12- to 17-year-olds

By | August 17, 2021
An extension to the current UK approval of the Spikevax vaccine (formerly COVID-19 Vaccine Moderna) that allows its use in 12- to 17-year-olds has today been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).